Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and ...

In this podcast, Motley Fool analyst Karl Thiel joins host Ricky Mulvey to check in on the GLP-1 landscape. They discuss: How ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest ...

A naturally occurring molecule that works as effectively as other semaglutide-based drugs — without the common side effects — ...

Dr. Bhardwaj's pioneering approach has earned him widespread recognition, including the prestigious title of "World's Fastest ...

Novo Nordisk reported results on its next-generation obesity drug in diabetes patients, including data on weight loss that ...

It's not too often that pharmaceutical drugs become household names, but that's happening with medicines in the weight loss market. Brands such as Wegovy and Zepbound -- the leading anti-obesity ...

Researchers linked higher weight loss after initiating antiobesity meds to lower risk for revision of hip and knee replacement.

It seems like no matter what I do, I can't lose weight. Most of my family members struggle with their weight too. Do our ...